Pivotal bioVenture Partners Investment Advisor as of March 31, 2026
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 13 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte (PCVX) | 28.5 | $80M | 1.4M | 58.11 | |
| Oculis Holding Ordinary Shares (OCS) | 16.0 | $45M | 1.7M | 26.59 | |
| Evommune Com Shs (EVMN) | 15.8 | $44M | 1.9M | 22.99 | |
| Arcutis Biotherapeutics (ARQT) | 11.4 | $32M | 1.4M | 23.56 | |
| Trevi Therapeutics (TRVI) | 6.6 | $19M | 1.6M | 11.93 | |
| Immunome (IMNM) | 5.7 | $16M | 733k | 21.87 | |
| Maplight Therapeutics (MPLT) | 4.4 | $12M | 611k | 20.33 | |
| Zenas Biopharma (ZBIO) | 4.1 | $12M | 592k | 19.55 | |
| Bioage Labs (BIOA) | 4.1 | $11M | 653k | 17.49 | |
| Avalo Therapeutics Com New (AVTX) | 1.6 | $4.4M | 296k | 14.93 | |
| Rallybio Corp (RLYB) | 1.0 | $2.7M | 301k | 8.97 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.7 | $1.8M | 596k | 3.07 | |
| Bolt Biotherapeutics Com New (BOLT) | 0.1 | $172k | 43k | 4.04 |
